Reuters

Serum expects a decision on an Indian trial of Novavax’s vaccine soon, said Adar Poonawalla

Novavax is stockpiling vaccine at six operating manufacturing locations and said it expects a total of eight plants in seven…

Novartis last year agreed to license two of Molecular Partners’ antiviral drugs that it hopes to use to treat COVID-19 patients

Most countries in Africa are unlikely to get widespread vaccination coverage until early 2023, while many Asian countries will…

Under the offer, shareholders would receive a price of $17.26 per Advanz Pharma share

An agreement with the Pfizer has been reached, informed Paul Hudson

Further talks with GSK will depend on the results of its due-diligence process

The company said it found no reduction in the antibody response against the variant found in Britain

Data released in November from Moderna’s late-stage study showed it was 94.1 per cent effective with no serious safety concerns

The aim was to get the companies to meet the vaccine volumes they had promised and not to seek compensation, said Foreign Minister…